MoonLake Immunotherapeutics announces landmark Phase 2 results for Nanobody® sonelokimab in active psoriatic arthritis
First
New York, Nov. 03, 2023 (GLOBE NEWSWIRE) — The Open Society Foundations is pleased to
VICTOR, N.Y., Nov. 03, 2023 (GLOBE NEWSWIRE) — Constellation Brands, Inc. (NYSE: STZ), a leading
EHang Opens its European Urban Air Mobility Center for eVTOL Aircraft, in Spain ALGUAIRE, Spain,
New Kit offers BioXp automation workflow from candidate sequence to amplified DNA in days SAN
Ahead of the Black Friday and Cyber Monday rush, LambdaTest is offering a flat 30%